These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38130271)

  • 1. Comparison between a novel salivary marker and several clinical prognosticators in oral cavity cancer.
    Lee YC; Lee LY; Huang Y; Kao HK; Chang YT; Hung SY; Lu CY; Chang YS; Yu JS; Chang KP
    Laryngoscope Investig Otolaryngol; 2023 Dec; 8(6):1547-1556. PubMed ID: 38130271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum and salivary levels of chemerin and MMP-9 in oral squamous cell carcinoma and oral premalignant lesions.
    Ghallab NA; Shaker OG
    Clin Oral Investig; 2017 Apr; 21(3):937-947. PubMed ID: 27161218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of salivary MMP-9 in oral squamous cell carcinoma and oral leukoplakia using ELISA.
    Pazhani J; Chanthu K; Jayaraman S; Varun BR
    J Oral Maxillofac Pathol; 2023; 27(4):649-654. PubMed ID: 38304520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma Matrix Metalloproteinase-1 as a Prognostic Biomarker in Oral Cavity Squamous Cell Carcinoma.
    Tsai TY; Kao HK; Huang Y; Chang YT; Young CK; Hung SY; Chang YS; Yu JS; Chang KP
    Cancer Manag Res; 2022; 14():3459-3468. PubMed ID: 36545225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and prognostic ability of salivary MMP-9 for oral squamous cell carcinoma: A pre-/post-surgery case and matched control study.
    Shin YJ; Vu H; Lee JH; Kim HD
    PLoS One; 2021; 16(3):e0248167. PubMed ID: 33735248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Verification of Saliva Matrix Metalloproteinase-1 as a Strong Diagnostic Marker of Oral Cavity Cancer.
    Chang YT; Chu LJ; Liu YC; Chen CJ; Wu SF; Chen CH; Chang IY; Wang JS; Wu TY; Dash S; Chiang WF; Chiu SF; Gou SB; Chien CY; Chang KP; Yu JS
    Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32823758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of salivary matrix metalloproteinases- 12 (MMP- 12) levels among patients presenting with oral submucous fibrosis and oral squamous cell carcinoma.
    Saleem Z; Shaikh AH; Zaman U; Ahmed S; Majeed MM; Kazmi A; Farooqui WA
    BMC Oral Health; 2021 Apr; 21(1):205. PubMed ID: 33892690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating Anti-Matrix Metalloproteinase-7 Antibodies May Be a Potential Biomarker for Oral Squamous Cell Carcinoma.
    Jiang T; Xie P; Liu H
    J Oral Maxillofac Surg; 2016 Mar; 74(3):650-7. PubMed ID: 26454036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovering the Clinical and Prognostic Role of Pan-Immune-Inflammation Values on Oral Cavity Squamous Cell Carcinoma.
    Yeh CC; Kao HK; Huang Y; Tsai TY; Young CK; Hung SY; Lu CY; Chang KP
    Cancers (Basel); 2023 Jan; 15(1):. PubMed ID: 36612318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of angiogenic factors and matrix metalloproteinases in the saliva of oral squamous cell carcinoma patients: potential non-invasive diagnostic and therapeutic biomarkers.
    Cai M; Zheng Z; Bai Z; Ouyang K; Wu Q; Xu S; Huang L; Jiang Y; Wang L; Gao J; Pathak JL; Wu L
    BMC Cancer; 2022 May; 22(1):530. PubMed ID: 35545767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Prediction Value of the Systemic Inflammation Score for Oral Cavity Squamous Cell Carcinoma.
    Eltohami YI; Kao HK; Lao WW; Huang Y; Abdelrahman M; Liao CT; Yen TC; Chang KP
    Otolaryngol Head Neck Surg; 2018 Jun; 158(6):1042-1050. PubMed ID: 29336202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salivary MMP-9 in the detection of oral squamous cell carcinoma.
    Peisker A; Raschke GF; Fahmy MD; Guentsch A; Roshanghias K; Hennings J; Schultze-Mosgau S
    Med Oral Patol Oral Cir Bucal; 2017 May; 22(3):e270-275. PubMed ID: 28160595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A histopathological evaluation and potential prognostic implications of oral squamous cell carcinoma with adverse features.
    Chang WC; Chang CF; Li YH; Yang CY; Su RY; Lin CK; Chen YW
    Oral Oncol; 2019 Aug; 95():65-73. PubMed ID: 31345396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salivary MMP-9 as a Biomarker for the Diagnosis of Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma.
    Smriti K; Ray M; Chatterjee T; Shenoy RP; Gadicherla S; Pentapati KC; Rustaqi N
    Asian Pac J Cancer Prev; 2020 Jan; 21(1):233-238. PubMed ID: 31983189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased salivary AKR1B10 level: Association with progression and poor prognosis of oral squamous cell carcinoma.
    Ko HH; Peng HH; Cheng SJ; Kuo MY
    Head Neck; 2018 Dec; 40(12):2642-2647. PubMed ID: 30430672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of salivary levels of ErbB2 in oral squamous cell carcinoma.
    Jayarajkumar S; Ramamoorthi R; Muniapillai S; Gopalakrishnan S; Jayaseelan VP
    J Oral Maxillofac Pathol; 2023; 27(4):777. PubMed ID: 38304523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Salivary Mycobiome in a Cohort of Oral Squamous Cell Carcinoma Patients From Sudan Identifies Higher Salivary Carriage of
    Mohamed N; Litlekalsøy J; Ahmed IA; Martinsen EMH; Furriol J; Javier-Lopez R; Elsheikh M; Gaafar NM; Morgado L; Mundra S; Johannessen AC; Osman TA; Nginamau ES; Suleiman A; Costea DE
    Front Cell Infect Microbiol; 2021; 11():673465. PubMed ID: 34712619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of overexpressed karyopherin alpha 2 with poor survival and its contribution to interleukin-1β-induced matrix metalloproteinase expression in oral cancer.
    Wang CI; Yu CJ; Huang Y; Yi JS; Cheng HW; Kao HK; Lao WW; Chang KP
    Head Neck; 2018 Aug; 40(8):1719-1733. PubMed ID: 29542209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of serum and salivary tumor necrosis factor-α with histological grading in oral cancer and its role in differentiating premalignant and malignant oral disease.
    Krishnan R; Thayalan DK; Padmanaban R; Ramadas R; Annasamy RK; Anandan N
    Asian Pac J Cancer Prev; 2014; 15(17):7141-8. PubMed ID: 25227804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salivary Biomarkers for Detection of Oral Squamous Cell Carcinoma in a Taiwanese Population.
    Gleber-Netto FO; Yakob M; Li F; Feng Z; Dai J; Kao HK; Chang YL; Chang KP; Wong DT
    Clin Cancer Res; 2016 Jul; 22(13):3340-7. PubMed ID: 26847061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.